Circulating Tumor Cell Capture and Analysis Techniques

This technical report discusses the methodologies and challenges associated with circulating tumor cell (CTC) capture and analysis in the context of cancer diagnosis, monitoring, and treatment. It outlines the significance of liquid biopsy as a non-invasive alternative to solid tumor biopsy, emphasizing the role of CTCs and circulating tumor DNA (ctDNA) in providing insights into cancer characteristics. The report details the laboratory's focus on processing liquid biopsy samples for CTC capture, particularly in breast cancer, prostate cancer, and head and neck squamous cell carcinoma. It highlights the technical complexities faced during CTC isolation and enrichment, especially with head and neck squamous cell carcinoma due to the size and morphology of the tumor cells. Additionally, it discusses the importance of tailoring enrichment protocols based on cancer stage and CTC counts, as well as the use of commercial technologies like CellSearch and RareCyte for CTC capture. The report concludes with a discussion on the need for alternative capture technologies to improve detection rates across various cancer types.